Details for New Drug Application (NDA): 077132
✉ Email this page to a colleague
The generic ingredient in RISEDRONATE SODIUM is risedronate sodium. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the risedronate sodium profile page.
Summary for 077132
Tradename: | RISEDRONATE SODIUM |
Applicant: | Teva Pharms Usa |
Ingredient: | risedronate sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 077132
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 077132 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3098 | 0093-3098-29 | 12 BLISTER PACK in 1 CARTON (0093-3098-29) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19) |
RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 077132 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3098 | 0093-3098-44 | 4 BLISTER PACK in 1 CARTON (0093-3098-44) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-3098-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Oct 5, 2007 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 30MG | ||||
Approval Date: | Oct 5, 2007 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 35MG | ||||
Approval Date: | Oct 5, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription